https://www.selleckchem.com/products/AZD0530.html
ogists (2.5%), and other specialties (7.9%). The average duration of treatment was 36.9 (SE 2.4) months. More than one-third of AD users in W1 expressed dissatisfaction with their AD treatment which translated into changes in types of antidepressant in W2. Depression affects a sizable part of the general population in the US with a prevalence of MDD at 13.4%-16.5%; yet MDD remains largely undertreated as shown by the finding that only about half (52%) of individuals in this study who met the diagnostic criteria for MDD were treated with
Curtir
Comentario
Compartilhar
